Global Genomics Personalized Health 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI03241645

Publication Date:

March 4, 2024

Pages:

102

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Genomics Personalized Health market size was valued at US$ 9031.6 million in 2023. With growing demand in downstream market, the Genomics Personalized Health is forecast to a readjusted size of US$ 16210 million by 2030 with a CAGR of 8.7% during review period.
The research report highlights the growth potential of the global Genomics Personalized Health market. Genomics Personalized Health are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Genomics Personalized Health. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Genomics Personalized Health market.
The demand of Genomics Personalized Health is increasing owing to rise in the biopharmaceutical and healthcare industry. The other drivers for genomics personalized health the market are increase in prevalence of cancer, increase in geriatric population, increasing attentiveness towards health in emerging economies.
Key Features:
The report on Genomics Personalized Health market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Genomics Personalized Health market. It may include historical data, market segmentation by Type (e.g., NGS Platforms, RT-PCR), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Genomics Personalized Health market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Genomics Personalized Health market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Genomics Personalized Health industry. This include advancements in Genomics Personalized Health technology, Genomics Personalized Health new entrants, Genomics Personalized Health new investment, and other innovations that are shaping the future of Genomics Personalized Health.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Genomics Personalized Health market. It includes factors influencing customer ' purchasing decisions, preferences for Genomics Personalized Health product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Genomics Personalized Health market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Genomics Personalized Health market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Genomics Personalized Health market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Genomics Personalized Health industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Genomics Personalized Health market.
麻豆原创 Segmentation:
Genomics Personalized Health market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
NGS Platforms
RT-PCR
Microarray
Genetic Analyzers
Segmentation by application
Academics & Research Institutes
Diagnostic Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
QIAGEN
Illumina
Thermo Fisher Scientific
Bio-Rad
Roche
Lonza
INVITAE
Genetic Technologies
Interleukin Genetics
Eastern Biotech
DNA Genotek
UBiome
XCode Life

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Genomics Personalized Health 麻豆原创 Size 2019-2030
2.1.2 Genomics Personalized Health 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Genomics Personalized Health Segment by Type
2.2.1 NGS Platforms
2.2.2 RT-PCR
2.2.3 Microarray
2.2.4 Genetic Analyzers
2.3 Genomics Personalized Health 麻豆原创 Size by Type
2.3.1 Genomics Personalized Health 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Genomics Personalized Health 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Genomics Personalized Health Segment by Application
2.4.1 Academics & Research Institutes
2.4.2 Diagnostic Centers
2.5 Genomics Personalized Health 麻豆原创 Size by Application
2.5.1 Genomics Personalized Health 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Genomics Personalized Health 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Genomics Personalized Health 麻豆原创 Size by Player
3.1 Genomics Personalized Health 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Genomics Personalized Health Revenue by Players (2019-2024)
3.1.2 Global Genomics Personalized Health Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Genomics Personalized Health Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genomics Personalized Health by Regions
4.1 Genomics Personalized Health 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Genomics Personalized Health 麻豆原创 Size Growth (2019-2024)
4.3 APAC Genomics Personalized Health 麻豆原创 Size Growth (2019-2024)
4.4 Europe Genomics Personalized Health 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Genomics Personalized Health 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Genomics Personalized Health 麻豆原创 Size by Country (2019-2024)
5.2 Americas Genomics Personalized Health 麻豆原创 Size by Type (2019-2024)
5.3 Americas Genomics Personalized Health 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genomics Personalized Health 麻豆原创 Size by Region (2019-2024)
6.2 APAC Genomics Personalized Health 麻豆原创 Size by Type (2019-2024)
6.3 APAC Genomics Personalized Health 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genomics Personalized Health by Country (2019-2024)
7.2 Europe Genomics Personalized Health 麻豆原创 Size by Type (2019-2024)
7.3 Europe Genomics Personalized Health 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genomics Personalized Health by Region (2019-2024)
8.2 Middle East & Africa Genomics Personalized Health 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Genomics Personalized Health 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Genomics Personalized Health 麻豆原创 Forecast
10.1 Global Genomics Personalized Health Forecast by Regions (2025-2030)
10.1.1 Global Genomics Personalized Health Forecast by Regions (2025-2030)
10.1.2 Americas Genomics Personalized Health Forecast
10.1.3 APAC Genomics Personalized Health Forecast
10.1.4 Europe Genomics Personalized Health Forecast
10.1.5 Middle East & Africa Genomics Personalized Health Forecast
10.2 Americas Genomics Personalized Health Forecast by Country (2025-2030)
10.2.1 United States Genomics Personalized Health 麻豆原创 Forecast
10.2.2 Canada Genomics Personalized Health 麻豆原创 Forecast
10.2.3 Mexico Genomics Personalized Health 麻豆原创 Forecast
10.2.4 Brazil Genomics Personalized Health 麻豆原创 Forecast
10.3 APAC Genomics Personalized Health Forecast by Region (2025-2030)
10.3.1 China Genomics Personalized Health 麻豆原创 Forecast
10.3.2 Japan Genomics Personalized Health 麻豆原创 Forecast
10.3.3 Korea Genomics Personalized Health 麻豆原创 Forecast
10.3.4 Southeast Asia Genomics Personalized Health 麻豆原创 Forecast
10.3.5 India Genomics Personalized Health 麻豆原创 Forecast
10.3.6 Australia Genomics Personalized Health 麻豆原创 Forecast
10.4 Europe Genomics Personalized Health Forecast by Country (2025-2030)
10.4.1 Germany Genomics Personalized Health 麻豆原创 Forecast
10.4.2 France Genomics Personalized Health 麻豆原创 Forecast
10.4.3 UK Genomics Personalized Health 麻豆原创 Forecast
10.4.4 Italy Genomics Personalized Health 麻豆原创 Forecast
10.4.5 Russia Genomics Personalized Health 麻豆原创 Forecast
10.5 Middle East & Africa Genomics Personalized Health Forecast by Region (2025-2030)
10.5.1 Egypt Genomics Personalized Health 麻豆原创 Forecast
10.5.2 South Africa Genomics Personalized Health 麻豆原创 Forecast
10.5.3 Israel Genomics Personalized Health 麻豆原创 Forecast
10.5.4 Turkey Genomics Personalized Health 麻豆原创 Forecast
10.5.5 GCC Countries Genomics Personalized Health 麻豆原创 Forecast
10.6 Global Genomics Personalized Health Forecast by Type (2025-2030)
10.7 Global Genomics Personalized Health Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Genomics Personalized Health Product Offered
11.1.3 QIAGEN Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Illumina
11.2.1 Illumina Company Information
11.2.2 Illumina Genomics Personalized Health Product Offered
11.2.3 Illumina Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Illumina Main Business Overview
11.2.5 Illumina Latest Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Information
11.3.2 Thermo Fisher Scientific Genomics Personalized Health Product Offered
11.3.3 Thermo Fisher Scientific Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Thermo Fisher Scientific Main Business Overview
11.3.5 Thermo Fisher Scientific Latest Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad Genomics Personalized Health Product Offered
11.4.3 Bio-Rad Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Bio-Rad Main Business Overview
11.4.5 Bio-Rad Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Genomics Personalized Health Product Offered
11.5.3 Roche Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Lonza
11.6.1 Lonza Company Information
11.6.2 Lonza Genomics Personalized Health Product Offered
11.6.3 Lonza Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Lonza Main Business Overview
11.6.5 Lonza Latest Developments
11.7 INVITAE
11.7.1 INVITAE Company Information
11.7.2 INVITAE Genomics Personalized Health Product Offered
11.7.3 INVITAE Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 INVITAE Main Business Overview
11.7.5 INVITAE Latest Developments
11.8 Genetic Technologies
11.8.1 Genetic Technologies Company Information
11.8.2 Genetic Technologies Genomics Personalized Health Product Offered
11.8.3 Genetic Technologies Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Genetic Technologies Main Business Overview
11.8.5 Genetic Technologies Latest Developments
11.9 Interleukin Genetics
11.9.1 Interleukin Genetics Company Information
11.9.2 Interleukin Genetics Genomics Personalized Health Product Offered
11.9.3 Interleukin Genetics Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Interleukin Genetics Main Business Overview
11.9.5 Interleukin Genetics Latest Developments
11.10 Eastern Biotech
11.10.1 Eastern Biotech Company Information
11.10.2 Eastern Biotech Genomics Personalized Health Product Offered
11.10.3 Eastern Biotech Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Eastern Biotech Main Business Overview
11.10.5 Eastern Biotech Latest Developments
11.11 DNA Genotek
11.11.1 DNA Genotek Company Information
11.11.2 DNA Genotek Genomics Personalized Health Product Offered
11.11.3 DNA Genotek Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 DNA Genotek Main Business Overview
11.11.5 DNA Genotek Latest Developments
11.12 UBiome
11.12.1 UBiome Company Information
11.12.2 UBiome Genomics Personalized Health Product Offered
11.12.3 UBiome Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 UBiome Main Business Overview
11.12.5 UBiome Latest Developments
11.13 XCode Life
11.13.1 XCode Life Company Information
11.13.2 XCode Life Genomics Personalized Health Product Offered
11.13.3 XCode Life Genomics Personalized Health Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 XCode Life Main Business Overview
11.13.5 XCode Life Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.